Brief: Sight Sciences Q1 Revenue USD 19.3 Million Vs. IBES Estimate USD 18.4 Million
May 02 (Reuters) - Sight Sciences Q1 operating expenses USD 31.2 million. * Q1 gross margin 86% * Q1 net income USD -16.3 million vs. IBES estimate USD -14.6 million * Q1 gross profit USD 16.5 million
Recent news on Sight Sciences
See all newsSight Sciences raises FY 2026 revenue outlook
Brief: Sight Sciences Q1 Revenue USD 19.7 Million Vs. IBES Estimate USD 18.5 Million
Brief: Sight Sciences U.S. District Court Issued Order On Post-Trial Motions In Patent Infringement Case Against Alcon Originally Filed On Sep 16, 2021
Sight Sciences Q4 revenue rises 7%
Brief: Sight Sciences Announces Preliminary, Unaudited Fourth Quarter And Full Year 2025 Financial Highlights